Preoperative Multimodal Prehabilitation and Surgical Outcomes in Ovarian Cancer Cytoreduction: A Systematic Review

Vegy Supriadi, Hacantya Pradipta, Gatot Nyarumenteng Adhipurnawan Winarno


Abstract


Introduction: Cytoreductive surgery for ovarian cancer imposes substantial physiological stress and is associated with high postoperative morbidity, particularly in patients with advanced disease. Multimodal prehabilitation has been proposed to optimize the preoperative condition, but its effectiveness in ovarian cancer remains uncertain.
Objective: This study aims to evaluate the effects of multimodal prehabilitation on perioperative outcomes, functional capacity, and oncologic recovery in women undergoing cytoreductive surgery for epithelial ovarian cancer.
Methods: A systematic review was conducted following PRISMA guidelines. PubMed, Cochrane Library, and ScienceDirect were searched for studies assessing multimodal prehabilitation prior to ovarian cancer surgery. Eligible studies included observational and interventional designs reporting functional, perioperative, or oncologic outcomes. Data were synthesized narratively.
Results: Five studies (2022–2025) were included. Prehabilitation consistently improved preoperative functional capacity. Effects on postoperative complications and intensive care use were inconsistent; however, some studies reported shorter hospital stays and earlier initiation of adjuvant chemotherapy. All studies had a moderate risk of bias.
Conclusion: Multimodal prehabilitation may enhance functional capacity and support recovery, but current evidence remains limited. Further high-quality randomized trials are needed.

Prehabilitasi Multimodal Praoperatif dan Luaran Bedah pada Sitoreduksi Kanker Ovarium: Sebuah Tinjauan Sistematis

Abstrak
Pendahuluan: Pembedahan sitoreduktif pada kanker ovarium menimbulkan stres fisiologis yang signifikan dan berisiko tinggi menyebabkan morbiditas pascaoperasi, terutama pada pasien dengan penyakit stadium lanjut. Prehabilitasi multimodal telah dikembangkan untuk mengoptimalkan kondisi pasien sebelum operasi, namun efektivitasnya pada kanker ovarium masih belum jelas.
Tujuan: Penelitian ini bertujuan mengevaluasi secara sistematis pengaruh prehabilitasi multimodal terhadap luaran perioperatif, kapasitas fungsional, dan pemulihan onkologis pada pasien yang menjalani bedah sitoreduksi kanker ovarium epitel.
Metode: Tinjauan sistematis dilakukan sesuai pedoman PRISMA. Pencarian literatur dilakukan pada PubMed, Cochrane Library, dan ScienceDirect untuk studi yang mengevaluasi prehabilitasi multimodal sebelum operasi kanker ovarium. Studi observasional dan intervensional yang melaporkan luaran fungsional, perioperatif, atau onkologis diikutsertakan. Data disintesis secara naratif.
Hasil: Setelah dilakukan tinjauan lima studi antara tahun 2022-2025. Prehabilitasi secara konsisten meningkatkan kapasitas fungsional praoperasi. Dampaknya terhadap komplikasi pascaoperasi dan penggunaan perawatan intensif masih bervariasi, namun beberapa studi melaporkan penurunan lama rawat inap dan percepatan inisiasi kemoterapi adjuvan. Seluruh studi memiliki risiko bias sedang.
Kesimpulan: Prehabilitasi multimodal berpotensi meningkatkan kapasitas fungsional dan mendukung pemulihan pascaoperasi, namun bukti yang ada masih terbatas. Diperlukan uji acak terkontrol dengan desain yang lebih baik.

 


Keywords


Cytoreductive surgery; functional capacity; ovarian cancer; perioperative outcomes; prehabilitation

Full Text:

PDF

References


du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer. 2009 Mar 15;115(6):1234–44.

Rahmalia K, Sudiarta KE, Setianingsih H, Diarsvitri W. The Characteristics of Sociodemography, Histopathologic Features, Stage, and Management of Ovarian Cancer in Dr. Ramelan Navy Hospital Surabaya. Indonesian Journal of Cancer. 2024 June 27;18(2):130–6.

Raffaello WM, Kurniawan A. Sarcopenic Obesity in Cancer Patients: Focus on Pathogenesis. Indonesian Journal of Cancer. 2020 Sept 30;14(3):104.

Rutten IJG, van Dijk DPJ, Kruitwagen RFPM, Beets-Tan RGH, Olde Damink SWM, van Gorp T. Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients. J Cachexia Sarcopenia Muscle. 2016 Sept;7(4):458–66.

Wright JD, Chen L, Hou JY, Burke WM, Tergas AI, Ananth CV, et al. Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer. Obstet Gynecol. 2017 Sept;130(3):545–53.

Minnella EM, Awasthi R, Bousquet-Dion G, Ferreira V, Austin B, Audi C, et al. Multimodal Prehabilitation to Enhance Functional Capacity Following Radical Cystectomy: A Randomized Controlled Trial. Eur Urol Focus. 2021 Jan;7(1):132–8.

Gillis C, Li C, Lee L, Awasthi R, Augustin B, Gamsa A, et al. Prehabilitation versus rehabilitation: a randomized control trial in patients undergoing colorectal resection for cancer. Anesthesiology. 2014 Nov;121(5):937–47.

Diaz-Feijoo B, Agusti-Garcia N, Sebio R, López-Hernández A, Sisó M, Glickman A, et al. Feasibility of a Multimodal Prehabilitation Programme in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer: A Pilot Study. Cancers (Basel). 2022 Mar 23;14(7):1635.

van der Graaff S, Backhuijs TAM, de Kort FP, Lockhorst EW, Smedts HPM, Schreinemakers JMJ, et al. Feasibility and Effects of Implementing Multimodal Prehabilitation Before Cytoreductive Surgery in Patients with Ovarian Cancer: The Gynofit Multicenter Study. Cancers (Basel). 2025 Apr 22;17(9):1393.

Sebio-Garcia R, Celada-Castro C, Arguis MJ, Sisó M, Torné A, Tena B, et al. Multimodal prehabilitation improves functional capacity in patients with advanced ovarian cancer undergoing cytoreductive surgery. Int J Gynecol Cancer. 2026 Jan;36(1):101858.

Santa Mina D, Clarke H, Ritvo P, Leung YW, Matthew AG, Katz J, et al. Effect of total-body prehabilitation on postoperative outcomes: a systematic review and meta-analysis. Physiotherapy. 2014 Sept;100(3):196–207.

Joseph N, Clark RM, Dizon DS, Lee MS, Goodman A, Boruta D, et al. Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer. Gynecol Oncol. 2015 June;137(3):401–5.

Ljungqvist O, Scott M, Fearon KC. Enhanced Recovery After Surgery: A Review. JAMA Surg. 2017 Mar 1;152(3):292–8.

Silver JK, Baima J, Mayer RS. Impairment-driven cancer rehabilitation: an essential component of quality care and survivorship. CA Cancer J Clin. 2013 Sept;63(5):295–317.

Molenaar CJL, Papen-Botterhuis NE, Herrle F, Slooter GD. Prehabilitation, making patients fit for surgery - a new frontier in perioperative care. Innov Surg Sci. 2019 Dec;4(4):132–8.




DOI: http://dx.doi.org/10.24198/obgynia.v9i2.1119

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


     
 

Creative Commons License
Indonesian Journal of Obstetrics & Gynecology Science is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
  Web Analytics
  View My Stat